Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) — Stella

Home/Preterm Birth/

View on ClinicalTrials.gov

Recruiting

Back to Preterm Birth trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Thomas Jefferson University, Philadelphia, Pennsylvania

Key details

Phase

Early testing / Safety & dosing

Sponsor

Thomas Jefferson University

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Enrollment target

~400 participants

Started

June 2025

Primary completion

July 2029

Age range

16 Years – 55 Years

Sex

Female only

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.